CompletedNot Applicable

Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity

Denmark82 participantsStarted 2011-09

Plain-language summary

The objective of this study is to evaluate the effect of mindfulness-based cognitive therapy (MBCT) on physical symptoms attributed to chemical exposures, psychological distress, illness worry, quality of life, and illness perceptions in patients suffering from multiple chemical sensitivity (MCS). Furthermore, a secondary objective is to evaluate whether a possible symptom reduction is mediated by an increased level of mindfulness. The primary hypothesis is that the self-reported severity of MCS symptoms and the degree to which chemical exposures causes symptoms and the impact on daily life will be significantly improved in the MBCT treatment group as compared to the control group.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Fulfil Lacour's criteria for Multiple Chemical Sensitivity * Sign a written informed consent form Exclusion Criteria: * A psychotic or bipolar disorder * An acute psychiatric disorder requiring other treatment * Suicidal ideations * Current alcohol or drug abuse * Previously engaged in a mindfulness programme

What they're measuring

The Quick Environmental Exposure and Sensitivity Inventory (QEESI)

Timeframe: 8 weeks, 1 year follow up

Trial details

NCT IDNCT01240395

SponsorThe Danish Research Centre for Chemical Sensitivities

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-05

View on ClinicalTrials.gov More Multiple Chemical Sensitivity trials